Comment on CMS-2026-1256-0002
Versiti Blood Health, Inc.OpposeAdvocacy
Summary: Versiti Blood Health, Inc., a nonprofit organ procurement organization, opposes the proposed expansion of renal organ acquisition cost reconciliation to non-renal organs. They argue that the proposal exceeds CMS's statutory authority, ignores the operational realities and fixed costs of organ procurement, and threatens the financial stability necessary to maintain life-saving donation infrastructure.
Versiti Blood Health, Inc. appreciates the opportunity to provide comments on the FY 2027 Hospital Inpatient Prospective Payment Systems (IPPS) proposed rule (CMS-1849-P).
Please see the attached comment letter for Versiti’s detailed feedback, analysis, and recommendations regarding the proposed policies.